Sunday - February 01, 2026

Focal Segmental Glomerulosclerosis Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | B. Braun Melsungen, Beckman Coulter (Danaher), Baxter

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Focal Segmental Glomerulosclerosis pipeline constitutes 15+ key companies continuously working towards developing 18+ Focal Segmental Glomerulosclerosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading

ANX-007 A Comprehensive Forecast on the Accelerating Market Growth for Dry age-related macular degeneration by 2034

A leading healthcare research firm releases an in-depth ANX-007 market report, covering sales forecast, market size analysis, and insights through 2034.   [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on … Continue reading

Aviceda Therapeutics “AVD-104” Market size expansion of Several Folds by 2034

DelveInsight unveils an in-depth report on AVD-104 by Aviceda Therapeutics, featuring market landscape insights and sales forecasts through 2034.   [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on AVD-104 (Aviceda … Continue reading

Spinal Cord Injury Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Kringle Pharma, Neuroplast, AbbVie, and Mitsubishi Tanabe Pharma America

Spinal Cord Injury Market Insights, Epidemiology, and Market Forecast – 2034 The Key Spinal Cord Injury Companies in the market include – Kringle Pharma, Neuroplast, AbbVie, and Mitsubishi Tanabe Pharma America, among others. The Spinal Cord Injury market is expected … Continue reading

Interleukin-2 (IL-2) Market to Grow Rapidly Over the Next Decade by 2034, DelveInsight Observes | Eisai, Citius Oncology, Corvus Pharmaceuticals, ILTOO Pharma

Interleukin-2 Market Size, Target Population, Competitive Landscape & Market Forecast – 2034 The Key Interleukin-2 (IL-2) Companies in the market include – Eisai, Citius Oncology, Corvus Pharmaceuticals, ILTOO Pharma, Asher Biotherapeutics, Medicenna Therapeutics, and Alkermes. The Interleukin-2 (IL-2) market is … Continue reading